Open AccessThe 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part II
Author(s) -
Natalia Kozlovskaya,
S. Soloviev,
Е. А. Асеева,
Т. В. Попкова,
Tatiana Panafidina,
E. Nasonov,
А. М. Лила,
A. Mesnyankina,
Н. Ю. Никишина
Publication year - 2021
Publication title -
sovremennaâ revmatologiâ
Language(s) - English
Resource type - Journals
eISSN - 2310-158X
pISSN - 1996-7012
DOI - 10.14412/1996-7012-2021-1-9-14
Subject(s) - lupus nephritis , medicine , antiphospholipid syndrome , intensive care medicine , consensus conference , pregnancy , pediatrics , disease , thrombosis , biology , genetics
The paper presents the main provisions of the updated 2019 EULAR/ERA-EDTA guidelines for the lupus nephritis (LN) therapy, which have been prepared by an international group of rheumatologists, nephrologists, morphologists, and pediatricians. Part 2 of the article discusses additional therapy, monitoring, and prognosis for LN, and the management of patients with end-stage renal failure and antiphospholipid syndrome. Attention is paid to the problem of LN and pregnancy, as well as to the management of pediatric patients with kidney damage.